For chronic disc-related back pain, spinal injections may reduce nerve inflammation in the short term, while intra-annular fibrin injection targets the torn disc itself to support structural repair. Candidacy depends on diagnosis, severity, and treatment history — our clinical team evaluates each case individually before recommending a path forward.

At Valor Spine, we help patients understand the full range of available options rather than defaulting to approaches aimed only at short-term symptom control. This guide explains how spinal injections and biologic disc repair work, where each fits, and how patients can approach the decision with their care team.

Why Disc Damage Drives Chronic Back Pain

The spine’s intervertebral discs — the cushioning structures between vertebrae — have a tough outer layer called the annulus fibrosus and a gel-like center called the nucleus pulposus. Over time or after injury, these discs can degenerate, producing conditions such as annular tears, herniated discs, or degenerative disc disease.

Annular tears are among the more commonly overlooked drivers of persistent pain. When the outer fibrous ring tears, internal disc material can leak and irritate surrounding nerves, producing ongoing inflammation. Because discs have a limited blood supply, these tears often do not resolve without targeted intervention.

Back pain is one of the leading causes of disability worldwide — affecting a large share of adults at some point in their lives. For many patients, this is not a passing ache. It is a condition that limits work, mobility, and daily quality of life. The treatment path matters.

Spinal Injections: Symptom Management, Not Structural Repair

Spinal injections — most commonly epidural steroid injections (ESIs) or nerve blocks — deliver corticosteroids and sometimes anesthetic directly into the epidural space surrounding irritated nerves. The primary mechanism is anti-inflammatory: reducing swelling around a compressed nerve root to relieve pain signals.

When Injections Are Used

Injections are frequently part of a conservative management plan, particularly when pain is acute or when a clinician wants to create a window of reduced pain to support physical therapy participation. Common indications include sciatica, radiculopathy, and certain types of facet joint pain.

As a diagnostic tool, they can also help confirm whether a specific nerve or structure is contributing to a patient’s symptoms — information that may inform further treatment decisions.

Limitations of Spinal Injections

The relief injections provide is typically temporary. For many patients, symptoms return within weeks to months as the steroid’s effects diminish — because the underlying structural damage to the disc or annular ring has not been addressed.

Published clinical evidence has raised questions about the long-term efficacy of epidural steroid injections for chronic low back pain. Repeated injections also carry cumulative risks, including:

• Increased risk of infection
• Bleeding at the injection site
• Temporary numbness or weakness
• Elevated blood glucose, which is particularly relevant for patients with diabetes
• Reduced bone density with frequent high-dose use
• Adrenal suppression
• Rare risk of nerve injury

Because of these cumulative risks, most clinical guidelines recommend limiting injections to two or three per year. For patients with ongoing structural disc damage, injections alone are not a sufficient long-term strategy in most cases.

Expert Take

Injections serve a clear role in short-term pain reduction and diagnostic evaluation — but they work downstream of the structural problem. When the underlying disc is torn or degenerating, reducing the pain signal without addressing its source tends to produce cycles of temporary relief followed by symptom recurrence. This pattern is worth discussing candidly with your care team before committing to repeated injection cycles.

Biologic Disc Repair: Targeting the Structural Source

Intra-annular fibrin injection — referred to interchangeably as fibrin disc treatment or biologic disc repair — takes a fundamentally different approach. Rather than reducing inflammation around the nerve, the procedure aims to repair the damaged disc tissue itself.

Fibrin is a natural protein central to the body’s clotting and healing cascade. In this procedure, a precisely formulated fibrin preparation is injected into the torn annulus fibrosus under advanced imaging guidance. The goals are to seal the annular tear, limit continued leakage of nucleus material into the surrounding nerve space, and create a biologic scaffold that may support the body’s own repair processes within the disc.

How the Fibrin Procedure Works

Once placed, the fibrin acts as a biologic sealant within the disc’s outer layer. By closing the annular tear, it addresses the structural source of irritation rather than only the downstream inflammatory response. In patients who respond, this approach may help stabilize the disc over time — outcomes vary by individual case, and candidacy depends on factors including the nature and extent of disc damage, prior treatment history, and overall spinal health.

For patients who have experienced limited benefit from injections or physical therapy, the fibrin procedure represents a pathway that targets the root-cause pathology rather than the symptom. Learn more about how this compares to injection-based care in our overview of fibrin disc treatment beyond epidural injections.

What the Evidence Shows

Clinical studies on fibrin disc treatment show meaningful pain reduction and functional improvement in a substantial subset of patients — including some who had not responded to prior surgical interventions. This includes patients presenting with failed back surgery syndrome, a population with limited options under traditional care pathways.

Platelet-Rich Plasma (PRP) is another regenerative option studied for discogenic pain. Like fibrin treatment, PRP relies on the body’s own biology to stimulate tissue repair and operates on a similar principle of activating natural healing processes. Some patients may be appropriate candidates for one approach or the other depending on their specific diagnosis; our clinical team evaluates both options in the context of each patient’s complete case.

For a broader overview of available approaches, see our guide to 5 non-surgical disc treatments for chronic back pain.

Side-by-Side: How These Two Approaches Differ

The distinction between spinal injections and biologic disc repair reflects a fundamentally different treatment philosophy — not just a procedural difference.

1. Mechanism of action: Injections reduce inflammation around nerves. Intra-annular fibrin injection seals torn disc tissue and supports structural repair from within the disc itself.
2. Duration of effect: Injection relief is typically short-term, lasting weeks to a few months in many patients. Fibrin treatment aims for more durable improvement by addressing the underlying disc damage — though outcomes vary by case and individual response.
3. Root-cause focus: Injections do not repair disc tissue. The fibrin procedure directly targets the annular tear, which is frequently the structural origin of chronic discogenic pain.
4. Long-term trajectory: Repeated injection cycles do not interrupt disc degeneration. Biologic repair, in appropriately selected candidates, addresses the progression source and may reduce the likelihood of eventual surgical intervention.

Expert Take

Neither approach is inherently superior — the right choice depends on the patient’s diagnosis, goals, and clinical picture. What matters is whether the treatment being considered actually matches the structural problem that has been identified. A thorough evaluation, including advanced imaging, is the starting point for any credible treatment recommendation. Patients who ask their providers to explain the rationale for each option — and how it maps to their specific diagnosis — are better positioned to make decisions aligned with their long-term goals.

How to Approach This Decision

Start with an Accurate Diagnosis

Treatment selection should follow diagnosis, not precede it. An MRI is typically essential for identifying whether pain originates from an annular tear, herniated disc, foraminal narrowing, or another structural source. Without diagnostic clarity, any treatment — injection or otherwise — is addressing an assumption rather than a confirmed finding.

Clarify Your Treatment Goal

Short-term relief to support a specific phase of recovery — such as pain reduction during physical therapy — is a reasonable and appropriate goal for injections. If the goal is durable improvement and reduced dependence on repeat interventions, a regenerative approach targeting the disc itself may better match that objective. Your care team can help align the treatment plan with your actual priorities.

Consider the Long-Term Trajectory

Ongoing injection cycles do not address disc degeneration. Over time, untreated structural damage can progress, which narrows future options. Patients who explore annular tear repair earlier in their pain trajectory often have more treatment options available than those who arrive after years of failed conservative care. Timing is worth discussing with a specialist.

Seek a Specialist Familiar with Both Paths

The most useful consultation is with a provider who can evaluate your imaging, explain both injection-based and regenerative options honestly, and help you understand which approach — or which sequence — fits your situation. At Valor Spine, our clinical team conducts thorough evaluations before making any recommendations, and candidacy for the fibrin procedure is determined on an individual basis. Review our candidacy and evaluation information to understand what that process involves.

Our Approach at Valor Spine

Our clinical team focuses on non-surgical solutions for patients with disc-related back pain — particularly those who have not found durable relief through injections or physical therapy, or who are seeking to avoid surgery. We specialize in intra-annular fibrin injection for appropriately selected candidates, and we evaluate each patient’s imaging, history, and goals before discussing treatment options.

Chronic disc pain does not have to mean a permanent cycle of short-term relief and symptom return. If you’re ready to explore whether biologic disc repair may be appropriate for your situation, we encourage you to schedule a consultation with our team.